Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 11, 2007, Pages 1072-1078

  Hallstrand, Teal S ^a   Chi, Emil Y ^a   Singer, Alan G ^a   Gelb, Michael H ^a   Henderson Jr , William R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Asthma; Eicosanoid; Epithelial cell; Leukotriene; Macrophage

Indexed keywords

ICOSANOID; PHOSPHOLIPASE A2; ISOENZYME; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AIRWAY; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; EPITHELIUM CELL; EXERCISE; FATTY ACID SYNTHESIS; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPUTUM; WESTERN BLOTTING; BRONCHUS; CHEMISTRY; CLASSIFICATION; COHORT ANALYSIS; CYTOLOGY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RESPIRATORY SYSTEM;

ADOLESCENT; ADULT; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; COHORT STUDIES; EICOSANOIDS; EPITHELIAL CELLS; EXERCISE; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PHOSPHOLIPASES A2, SECRETORY; RESPIRATORY SYSTEM; SPUTUM;

EID: 36849093917     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200707-1088OC     Document Type: Article

References (53)

1. Hallstrand TS, Henderson WR Jr. Leukotriene modifiers. Med Clin North Am 2002;86:1009-1033.
2. Pavord ID, Ward R, Woltmann G, Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999;160:1905-1909.
3. Griffin M, Weiss JW, Leitch AG, McFadden ER Jr, Corey EJ, Austen KF, Drazen JM. Effects of leukotriene D on the airways in asthma. N Engl J Med 1983;308:436-439.
4. 2 in normal and asthmatic men. N Engl J Med 1984;311:209-213.
5. 2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis 1975;111:313-320.
6. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, et al. Indirect airway challenges. Eur Respir J 2003;21:1050-1068.
7. Currie GP, Haggart K, Lee DK, Fowler SJ, Wilson AM, Brannan JD, Anderson SD, Lipworth BJ. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy 2003;33:783-788.
8. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR Jr, Aitken ML. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005;172:679-686.
9. Mickleborough TD, Lindley MR, Ray S. Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma. Med Sci Sports Exerc 2005;37:904-914.
10. Carraro S, Corradi M, Zanconato S, Alinovi R, Pasquale MF, Zacchello F, Baraldi E. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005;115:764-770.
11. Hallstrand TS, Moody MW, Aitken ML, Henderson WR Jr. Airway immunopathology of asthma with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005;116:586-593.
12. 2 in inflammatory and allergic diseases: not just enzymes. J Allergy Clin Immunol 2005;116:1000-1006.
13. 2 in allergic response and parturition. Nature 1997;390:618-622.
14. 1 macrophage-like cells. J Biol Chem 2003;278:48059-48065.
15. 2-α. J Biol Chem 2004;279:25024-25038.
16. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J Biol Chem 2004;279:16488-16494.
17. 2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J Biol Chem 2006;281:16245-16255.
18. 2 during long-term stimulation of P388D1 cells with LPS. J Lipid Res 2005;46:2488-2496.
19. 2 does not alter leukotriene formation. J Biol Chem 1997;272:759-765.
20. 2-independent cysteinyl leukotriene synthesis in human eosinophils. J Biol Chem 2003;278:38813-38820.
21. Calabrese C, Triggiani M, Marone G, Mazzarella G. Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma. Allergy 2000;55:27-30.
22. 2. J Biol Chem 2002;277:48535-48549.
23. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997;155:421-425.
24. Chilton FH, Averill FJ, Hubbard WC, Fonteh AN, Triggiani M, Liu MC. Antigen-induced generation of lyso-phospholipids in human airways. J Exp Med 1996;183:2235-2245.
25. 2 from human nasal lavage. Am J Respir Cell Mol Biol 1994;11:108-113.
26. 2 isoenzymes in airway inflammatory cells of patients with mild asthma and exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2004;169:A569.
27. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J Biol Chem 2002;277:5061-5073.
28. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001;163:1470-1475.
29. Hallstrand TS, Debley JS, Farin FM, Henderson WR Jr. Role of MUC5AC in the pathogenesis of exercise-induced bronchoconstriction. J Allergy Clin Immunol 2007;119:1092-1098.
30. 2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma 2005;42:65-71.
31. 2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem 2006;281:36420-36433.
32. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 2007;204:865-877.
33. 2-β. J Biol Chem 1999;274:17063-17067.
34. 2. J Biol Chem 1998;273:21926-21932.
35. 2β, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. J Biol Chem 2003;278:22231-22236.
36. 2γ). Roles in the membrane remodeling and activation induced by oxidative stress. J Biol Chem 2003;278:8809-8814.
37. 2γ) protein expression. Am J Physiol Lung Cell Mol Physiol 2004;287:L497-L502.
38. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994;149:1138-1141.
39. 2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999;159:31-36.
40. 2 in airways of subjects with asthma. Am J Respir Crit Care Med 2000;162:637-640.
41. 4. Clin Exp Allergy 2007;37:880-892.
42. Peters-Golden M, Feyssa A. Transcellular eicosanoid synthesis in cocultures of alveolar epithelial cells and macrophages. Am J Physiol 1993;264:L438-L447.
43. 4 in eosinophils. J Immunol 2006;177:574-582.
44. 2 to induce eicosanoid biosynthesis in neighboring inflammatory cells. J Biol Chem 2006;281:10935-10944.
45. Anderson SD. How does exercise cause asthma attacks? Curr Opin Allergy Clin Immunol 2006;6:37-42.
46. Plummeridge MJ, Armstrong L, Birchall MA, Millar AB. Reduced production of interleukin 12 by interferon γ primed alveolar macrophages from atopic asthmatic subjects. Thorax 2000;55:842-847.
47. Alexis NE, Soukup J, Nierkens S, Becker S. Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol 2001;280:L369-L375.
48. Careau E, Proulx LI, Pouliot P, Spahr A, Turmel V, Bissonnette EY. Antigen sensitization modulates alveolar macrophage functions in an asthma model. Am J Physiol Lung Cell Mol Physiol 2006;290:L871-L879.
49. Balter MS, Toews GB, Peters-Golden M. Different patterns of arachidonate metabolism in autologous human blood monocytes and alveolar macrophages. J Immunol 1989;142:602-608.
50. Balter MS, Eschenbacher WL, Peters-Golden M. Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. Am Rev Respir Dis 1988;138:1134-1142.
51. 2. J Biol Chem 2000;275:39823-39826.
52. 2s (groups III and XII). J Biol Chem 2003;278:10657-10667.
53. 2. J Biol Chem 2002;277:5849-585